CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of 'major histocompatibility complex-deficient' skin grafts

Transplantation

Volumn 63, Issue 8, 1997, Pages 1123-1133

  Lee, Richard S ^a   Grusby, Michael J ^b   Laufer, Terri M ^b   Colvin, Robert ^a   Glimcher, Laurie H ^b   Auchincloss Jr , Hugh ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; GRAFT REJECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE ACTIVATION;

EID: 0030939879     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704270-00012     Document Type: Article

References (37)

1. Grusby MJ, Auchincloss H Jr, Lee R, et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA 1993; 90: 3919.
2. Dierich A, Chan SH, Benoist C, Mathis D. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules. Eur J Immunol 1993; 23: 2725.
3. Markmann JP, Bassiri H, Desai NM, et al. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation 1992; 54: 1085.
4. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes 1993; 42: 1520.
5. Coffman T, Geier S, Ibrahim S, et al. Improved renal function in mouse kidney allografts lacking MHC class I antigens. J Immunol 1993; 151: 425.
6. Xiangping L, Faustman D. Use of donor β-2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation 1993; 55: 940.
7. Markmann JF, Campos L, Bhandoola A, et al. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts. Surgery 1994; 116: 242.
8. Munn SR, Marjoribanks C. Current limitations to use of major histocompatibility complex transgenic donors for islet transplantation. Transplantation 1994; 57: 760.
9. Campos L, Naji A, Deli BC, et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187.
10. Billingham RE, Medawar PB. Technique of free skin grafting in mammals. J Exp Biol 1951; 28: 385.
11. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block cell-mediated cytolysis in the absence of complement. J Immunol 1980; 125: 2665.
12. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal Ab GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 1983; 131: 2445.
13. Koo GC, Peppard JR. Establishment of monoclonal anti NK 1.1 antibody. Hybridoma 1984; 3: 301.
14. Ghobrial RRM, Boublik M, Winn HJ, Auchincloss H Jr. In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol 1989; 52: 486.
15. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865.
16. Kappler JW, Skidmore B, White J, Marrack P. Antigen-induc-ible, H-2 restricted, interleukin-2-producing T cell hybridomas. J Exp Med 1981; 153: 1198.
17. Ozato K, Mayer N, Sachs DH. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 1980; 124: 533.
18. Koch N, Hammerling GJ, Tada N, Kimura S, Hammerling U. Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d, and k. Eur J Immunol 1982; 12: 909.
19. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts: I. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994; 144: 260.
20. Bix M, Raulet D. Functionally conformed free class I heavy chains exist on the surface of B2 microglobulin negative cells. J Exp Med 1992; 176: 829.
21. Glas R, Franksson L, Ohlen C, et al. Major histocompatibility complex class I-specific and -restricted killing of β2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1993; 89: 11381.
22. Markowitz JS, Auchincloss H Jr, Grusby MJ, Glimcher LH. Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 2779.
23. Burkly LC, Degermann S, Longley J, et al. Clonal deletion of V beta 5+ T cells by transgenic I-E restricted to thymic medullary epithelium. J Immunol 1993; 151: 3954.
24. Rosenberg AS, Mizuochi T, Singer A. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts: assessment of MHC class I alloantigens as in vivo helper determinants. J Exp Med 1988; 168: 33.
25. Auchincloss H Jr, Ghobrial RRM, Russell PS, Winn HJ. Anti-L3T4 in vivo prevents alloantibody formation after skin grafting without prolonging graft survival. Transplantation 1988; 45: 1118.
26. Heath WR, Kjer-Nielsen L, Hoffmann MW. Avidity for antigen can influence the helper dependence of CD8+ T lymphocytes. J Immunol 1993; 151: 5993.
27. Auchincloss H Jr, Mayer T, Ghobrial R, Winn HJ. T cell subsets, bm mutants, and the mechanism of allogeneic skin graft rejection. Immunol Res 1989; 8: 149.
28. Mitchison NA, O'Malley C. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur J Immunol 1987; 17: 1579.
29. Keene J-A, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982; 155: 768.
30. Rosenberg AS, Mizuochi T, Sharrow SO, Singer A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 1987; 165: 1296.
31. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314: 537.
32. Tucker MJ, Bretscher PA. T cells cooperating in the induction of delayed-type hypersensitivity act via the linked recognition of antigenic determinants. J Exp Med 1982; 155: 1037.
33. Wecker H, Grusby MJ, Auchincloss H Jr. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice. Transplantation 1995; 59: 1223.
34. Rosenberg AS, Munitz TI, Maniero TG, Singer A. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo. J Exp Med 1991; 173: 1463.
35. Doody DP, Stenger KS, Winn HJ. Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts. J Exp Med 1994; 179: 1645.
36. Sundt III TM, Guzzetta PC, Suzuki T, Rosengard BS, Sachs DH. The influence of bone marrow derived elements on renal allograft rejection. Surg Forum 1990; 60: 375.
37. Campos L, Naji A, Deli BC, et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187.